Flowerkist Skin Care & Cosmetics Inc Financials

FKST

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2022 Currency USD FYE December

This page shows Flowerkist Skin Care & Cosmetics Inc (FKST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FKST FY2021 2026-04-22

Recent filings show a maintenance-mode company funded externally, with administrative losses replacing any visible operating activity.

In FY2020-FY2021, operating cash burn, net loss, and SG&A were essentially the same figure each year, while financing inflows offset that burn almost dollar for dollar. That pattern usually appears when there is little business engine left in the statements: cash needs look like the cost of keeping the corporate structure alive, not the working-capital demands of a selling company.

Before the latest low-activity years, the balance sheet already showed negative equity of -$620K and a current ratio of 0.1x, meaning short-term obligations outweighed near-term resources. Because most current assets were inventory rather than cash, that thin cushion was even less flexible than the ratio alone suggests.

Commercial scale never covered the financing burden: gross margin reached 67.3% while revenue stayed below $20K, which points away from weak markup as the main problem. The real constraint was a cost structure and capital burden far too large for the sales base to absorb.

Financial Health Signals

Financial Profile 0/100

Based on FY2021 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Flowerkist Skin Care & Cosmetics Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings Quality Low Quality

1.00x

For every $1 of reported earnings, Flowerkist Skin Care & Cosmetics Inc generates $1.00 in operating cash flow (-$2K OCF vs -$2K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$2K

YoY+63.7%

Flowerkist Skin Care & Cosmetics Inc reported -$2K in net income in fiscal year 2021. This represents an increase of 63.7% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

130,212

Flowerkist Skin Care & Cosmetics Inc had 130,212 shares outstanding in fiscal year 2021.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

FKST Income Statement

Metric	FY21	FY20	FY16	FY15	FY14	FY13
Revenue	N/A	N/A	$12K-40.3%	$20K	$0	N/A
Cost of Revenue	N/A	N/A	$4K-63.9%	$11K	$0	N/A
Gross Profit	N/A	N/A	$8K-12.4%	$9K	$0	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2K-63.7%	$5K-98.6%	$386K+357.1%	$84K-10.6%	$94K	N/A
Operating Income	-$2K+63.7%	-$5K+99.0%	-$561K-41.0%	-$398K-77.0%	-$225K	N/A
Interest Expense	N/A	N/A	-$230K+20.6%	-$290K-1430.3%	-$19K	N/A
Income Tax	N/A	N/A	N/A	$0	$0	$0
Net Income	-$2K+63.7%	-$5K+99.3%	-$791K	N/A	-$195K	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q4'20	Q3'20	Q3'19	Q3'18
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$16K	N/A	$22K	N/A	N/A	N/A	N/A	N/A
Operating Income	-$16K	N/A	-$22K	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$16K	N/A	-$22K	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

FKST Balance Sheet

Metric	FY21	FY20	FY16	FY15	FY14	FY13
Total Assets	$0	N/A	$0-100.0%	$81K-29.6%	$115K+5741350.0%	$2
Current Assets	N/A	N/A	N/A	$66K-24.4%	$87K+4353750.0%	$2
Cash & Equivalents	N/A	N/A	$663-95.2%	$14K-32.5%	$20K+1018850.0%	$2
Inventory	N/A	N/A	N/A	$52K-19.2%	$64K	$0
Accounts Receivable	N/A	N/A	N/A	N/A	$2K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2K	N/A	$878K+25.3%	$701K+208.9%	$227K+162.4%	$86K
Current Liabilities	$2K	N/A	$835K+27.0%	$658K	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2K+99.8%	-$878K0.0%	-$878K-41.7%	-$620K-453.5%	-$112K-29.6%	-$86K
Retained Earnings	-$3.4M	N/A	-$1.8M-46.7%	-$1.2M-140.2%	-$507K-372.4%	-$107K

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q4'20	Q3'20	Q3'19	Q3'18
Total Assets	$0	$0	$0	$0	$0-100.0%	$5K	$0	$0
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$39K+67.4%	$24K0.0%	$24K+1095.3%	$2K-63.1%	$5K-99.4%	$883K+0.6%	$878K0.0%	$878K
Current Liabilities	$39K+67.4%	$24K0.0%	$24K+1095.3%	$2K-63.1%	$5K-99.4%	$840K+0.7%	$835K0.0%	$835K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$39K-67.4%	-$24K0.0%	-$24K-1095.3%	-$2K+63.1%	-$5K+99.4%	-$878K0.0%	-$878K0.0%	-$878K
Retained Earnings	-$3.4M-0.5%	-$3.4M0.0%	-$3.4M-0.6%	-$3.4M-0.1%	-$3.4M-88.2%	-$1.8M-0.3%	-$1.8M0.0%	-$1.8M

FKST Cash Flow Statement

Metric	FY21	FY20	FY16	FY15	FY14	FY13
Operating Cash Flow	-$2K+63.7%	-$5K+96.4%	-$150K+61.2%	-$387K-52.5%	-$254K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	$0	$0
Free Cash Flow	N/A	N/A	N/A	N/A	-$2	N/A
Investing Cash Flow	N/A	N/A	N/A	$1K+104.2%	-$27K	$0
Financing Cash Flow	$2K-63.7%	$5K-96.0%	$137K-64.1%	$381K+26.3%	$301K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q4'20	Q3'20	Q3'19	Q3'18
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

FKST Financial Ratios

Metric	FY21	FY20	FY16	FY15	FY14	FY13
Gross Margin	N/A	N/A	67.3%+21.4pp	45.9%	N/A	N/A
Operating Margin	N/A	N/A	-4674.4%-2694.9pp	-1979.5%	N/A	N/A
Net Margin	N/A	N/A	-6593.7%	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	-170.2%	N/A
Current Ratio	N/A	N/A	N/A	0.10	N/A	N/A
Debt-to-Equity	-1.00	N/A	-1.00+0.1	-1.13+0.9	-2.03-1.0	-1.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q4'20	Q3'20	Q3'19	Q3'18
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	-1.000.0	-1.000.0	-1.000.0	-1.000.0	-1.000.0	-1.010.0	-1.000.0	-1.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$2K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Is Flowerkist Skin Care & Cosmetics Inc profitable?

No, Flowerkist Skin Care & Cosmetics Inc (FKST) reported a net income of -$2K in fiscal year 2021.

What is Flowerkist Skin Care & Cosmetics Inc's operating cash flow?

Flowerkist Skin Care & Cosmetics Inc (FKST) generated -$2K in operating cash flow during fiscal year 2021, representing cash generated from core business activities.

What are Flowerkist Skin Care & Cosmetics Inc's total assets?

Flowerkist Skin Care & Cosmetics Inc (FKST) had $0 in total assets as of fiscal year 2021, including both current and long-term assets.

How many shares does Flowerkist Skin Care & Cosmetics Inc have outstanding?

Flowerkist Skin Care & Cosmetics Inc (FKST) had 130,212 shares outstanding as of fiscal year 2021.

What is Flowerkist Skin Care & Cosmetics Inc's debt-to-equity ratio?

Flowerkist Skin Care & Cosmetics Inc (FKST) had a debt-to-equity ratio of -1.00 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Flowerkist Skin Care & Cosmetics Inc's debt-to-equity ratio negative or unusual?

Flowerkist Skin Care & Cosmetics Inc (FKST) has negative shareholder equity of -$2K as of fiscal year 2021, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Are Flowerkist Skin Care & Cosmetics Inc's earnings high quality?

Flowerkist Skin Care & Cosmetics Inc (FKST) has an earnings quality ratio of 1.00x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Flowerkist Skin Care & Cosmetics Inc?

Flowerkist Skin Care & Cosmetics Inc (FKST) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.